Retinal vein branch occlusion and palsy of the N. abducens in protein S deficiency: A genealogical investigation;Venenastverschluss und abduzensparese bei protein-S-mangel: Eine genealogische untersuchung

Ophthalmologe

Volumn 102, Issue 3, 2005, Pages 279-285

  Holak, H M ^a   Holak, N H ^a   Holak, S ^b   Holak, S A ^c   Szymaniec, S ^d  

^a Gemeinschaftspraxis Augenarzte R   (Germany)

^b Augenklinik Stadtischen Klinikums B

^c Schlosspark Klinik   (Germany)

^d INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

Author keywords

Abducens palsy; Genealogy; Protein S deficiency; Retinal vein occlusion

Indexed keywords

ABDUCENS NERVE PARALYSIS; ARTICLE; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; FLUORESCENCE ANGIOGRAPHY; HUMAN; ILIAC VEIN; LUNG EMBOLISM; MORPHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYLOGENY; POSTTHROMBOSIS SYNDROME; PROTEIN S DEFICIENCY; RETINA VEIN; RISK ASSESSMENT; VEIN OCCLUSION; VEIN THROMBOSIS;

ABDUCENS NERVE DISEASES; ADOLESCENT; ADULT; CHROMOSOMES, HUMAN, PAIR 3; DNA MUTATIONAL ANALYSIS; FEMALE; FLUORESCEIN ANGIOGRAPHY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTRACRANIAL EMBOLISM; MALE; MIDDLE AGED; PEDIGREE; PHENOTYPE; POINT MUTATION; PROTEIN S; PROTEIN S DEFICIENCY; PULMONARY EMBOLISM; RETINAL VEIN OCCLUSION; THROMBOPHILIA; VENOUS THROMBOSIS;

EID: 16844383631     PISSN: 0941293X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00347-004-1032-2     Document Type: Article

References (47)

1. Abu El-Asrar AM, Al-Momem AK, Al-Amro S et al. (1996) Prothrombotic states associated with retinal venous occlusion in youg adults. Int Ophthalmol 20:197-204
2. Aras S, Yilmaz G, Alpas I et al. (2001) Retinal vein occlusion and factor V Leiden and prothrombin 20210 G:A mutations. Eur J phthalmol 11:351-355
3. Bertram B, Remky A, Arend O et al. (1995) Protein C, protein S, and antithrombin III in acute ocular diseases. Germ J Ophthalmol 4:332-335
4. Biouse V (1999) Coagulation abnormalities and their neuro-ophthalmologic manifestations. Curr Opin Ophthalmol 10:382-393
5. Broekmans AW, Bertina RM, Reinalda-Poot et al. (1985) Hereditary protein S deficiency and venous thrombo-embolism: a study of three dutch families. Thromb Haemost 53:273-277
6. Ciardella AR Yannuzzi LA, Freund KB et al. (1998) Faktor V Leiden, activated protein C resistence, and retinal vein occlusion. Retina 18:308-315
7. Comp PC, Nixon RR, Cooper MR, Esmon CT (1984) Familial protein S deficiency is associated with recurrent thrombosis. J Clin Invest 74:2082-2088
8. D'Angelo A, Vigano-d'Angelo S, Esmon CT, Comp PC (1988) Aquired deficiency of protein S. Protein S activity during oral anticoagulation, in liver disease, and in disseminated intravascular coagulation. J Clin Invest 81:1445-1454
9. Dhôte R, Bachmeyer C, Horellou MH et al. (1995) Central retinal vein thrombosis associated with resistance to activated protein C. Am J Ophthalmol 120:388-389
10. Engesser L, Broekmans AW, Briet E et al. (1987) Hereditary protein S deficiency: clinical manifestations. Ann Intern Med 106:677-682
11. Faude S, Faude F, Siegemund A, Wiedemann P (1999) APC-Resistenz bei Patienten mit Zentralvenenverschluß. Ophthalmologe 96:594-599
12. Fegan CD (2002) Central retinal vein occlusion and thrombophilia. Eye 16:98-106
13. Fujimura H, Kambayashi JI, Kalo H et al. (1998) Three novel missense mutations in unrelated Japanese patients with type I and type II protein S deficiency and venous thrombosis. Thromb Res 89:151-160
14. Giri TK, Linse S, de Frutos PG et al. (2002) Structural requirements of anticoagulant protein S for its binding to the complement regulator C4b- binding protein. J Biol Chem 277:15099-15106
15. Girolami A, Simioni P, Lazzaro AR, Cordiano I (1989) Severe arterial cerebral thrombosis in a patient with protein S deficiency (moderately reducecd total and markedly reduced free protein S): a family study. Thromb Haemost 61:144-147
16. Glueck CJ, Bell H, Vadlamani L et al. (1999) Heritable thrombophilia and hypofibrinolysis: posible causes of retinal vein occlusion. Arch Ophthalmol 117:43-49
17. Golub BM, Sibony DA, Coller BS (1990) Protein S deficiency associated with central retinal artery occlusion. Arch Ophthalmol 108:918
18. Grandrille S, Borgel D, Ireland H et al. (1997) Protein S deficiency: a data base of mutations. For the plasma coagulation inhibitors subcommittee of the scientific and standarisation committee of the international society on thrombosis and haemostasis. Thromb Haemost 77:1201-1214
19. Greiner K, Hafner G, Dick B et al. (1999) Retinal vascular occlusion and deficiences of the protein C pathway. Am J Ophthalmol 128:69-74
20. Greiner K, Hafner G, Prellwitz W, Pfeiffer N (1999) Hereditäre Störungen des Protein-C-Systems bei Zentralarterien- and Arteriolenastverschlüssen. Klin Monatsbl Augenheilkd 215:33-36
21. Greven CM, Weaver RG, Owen J, Slusher MM (1991) Protein S deficiency and bilateral branch retinal artery occlusion. Ophthalmology 98:33-34
22. Guven D, Sayinalp N, Kalayci D et al. (1999) Risk faktors in central vein occlusion and activated protein C resistance. Eur J Ophthalmol 9:43-48
23. Hayreh SS, Zimmerman MB, Podhajski P (2002) Hematologic abnormalities associated with various types of retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 240:189-196
24. Holmes ZR, Bertina RM, Reitsma PH (1996) Characterisation of a large chromosomal deletion in the PROS1 gene of the patient with protein S deficiency type I using long PCR. Br J Haematol 92:986-991
25. Iijima H, Gohdo T, Imai M, Tsukahara S (1998) Thrombin-antithrombin III complex in acute retinal vein occlusion. Am J Ophthalmol 126:677-682
26. Lahey MJ, Kearney JJ, Tune M (2003) Hypercoagulable states and central retinal vein occlusion. Curr Opin Pulm Med 9:385-392
27. Lahey MJ, Tunc M, Kearney J et al. (2002) Laboratory evaluation of hypercoagulable states in patients with central retinal vein occlusion who are less than 56 years old. Ophthalmology 109:126-131
28. Larsson J, Hillarp A, Olafsdottir E, Bauer B (1999) Activated protein C resistance and anticoagulant proteins in young adults with central retinal vine occlusion. Acta Ophthalmol Scand 77:634-637
29. Lerche RC, Wilhelm C, Eifrig B, Richard G (2001) Thrombophiliefaktoren als Auslöser retinaler Gefäßverschlüsse. Ophthalmologe 98:529-534
30. Leroy-Matheron C, Gouault-Heilmann M, Aiach M, Gandrille S (1998) A mutation of the active protein S gene leading to EGF1-lacking protein in a family with qualitative (type II) deficiency. Blood 91:4608-4615
31. Liberti G, Bertina RM, Rosendaal FR (1999) Hormonal state rather then age influence cut-off values of protein S: reevaluation of the thrombotic risk associated with protein S deficiency. Thromb Haemost 82:1093-1096
32. Mahasandana C, Suvatte V, Marlar RA et al. (1990) Neonatal purpura fulminans associated with homozygous protein S deficiency. Lancet 335:61-62
33. Malm J, Bennhagen R, Holmberg L, Dahlbäck B (1988) Changes in the plasma levels of vitamin K-dependent protein C and S and C4b-binding protein during pregnancy and oral contraception. Br J Haematol 68:437-443
34. Martinelli I, Manucci PM, De Stefano et al. (1998) Different risk of thrombosis in four coagulation deffects associated with inherited thrombophilia: a study of 150 families. Blood 92:2353-2358
35. Pegelow CH, Ledford M, Young J, Zilleruelo G (1992) Severe protein S deficiency in a newborn. Pediatrics 89:674-676
36. Prince HM, Thurlow PJ, Buchanan RC et al. (1995) Acquired protein S deficiency in a patient with systemic lupus erythematous causing central retinal vein thrombosis. J Clin Pathol 48:387-389
37. Scat Y, Morin Y, Morel C, Haut J (1995) Occlusion veineuse da la rétine et résistance à la protéine C activée. J Fr Ophthalmol 18:758-762
38. Simmonds RE, Zöller B, Ireland H et al. (1997) Genetic and phenotypic analysis of a large (122-member) protein S-deficient kindred provides an explanation for the familial coexistence of type I and type III plasma phenotypes. Blood 89:4364-4370
39. Talmon T, Scharf J, Mayer E et al. (1997) Retinal arterial occlusion in a child with factor V Leiden and their molabile methylene reductase mutations. Am J Ophthalmol 124:689-691
40. Takayashi H, Wada K, Hayashi S et al. (1988) Behaviour of protein S during long-term oral anticoagulant therapy. Thromb Res 51:241-245
41. Takayashi H, Tatewaki W, Wada K, Shibata A (1989) Plasma protein S in disseminated intravascular coagulation, liver disease, collagen disease, diabetes mellitus, and other anticoagulant therapy. Clin Chem Acta 182:195-208
42. Tekeli O, Gursel E, Buyurgan H (1999) Protein C, protein S and antithrombin III deficiencies in retinal vein occlusion. Acta Ophthalmol Scand 77:628-630
43. Vine AK, Samama MM (1993) The role of abnormalities in the anticoagulant and fibrinolytic systems in the retinal vascular occlusions. Surv Ophthalmol 37:283-292
44. Vine AK, Samama MM (1997) Screening for resistance to activated protein C and the mutant gene for factor V:Q506 in the patients with central retinal vein occlusion. Am J Ophthalmol 124:673-676
45. Williamson TH (1997) Central retinal vein occlusion: what's the story. Br J Ophthalmol 81:689-704
46. Williamson TH, Rumley A, Lowe GDO (1996) Blood viscosity, coagulation, and activated protein C resistance in central retinal vein occlusion: a population controlled study. Br J Ophthalmol 80:203-208
47. Zöller B, Garcia de Frutos P, Dahlbäck B (1995) Evaluation of the relationship between protein S and binding C4b-binding protein isoforms in hereditary protein S deficiency demonstrating type I and type III deficiencies to be phenotypic variants of the same genetic disease. Blood 85:3524-3531